AHCPR GUIDELINE ON MANAGEMENT OF CANCER-RELATED PAIN
This article was originally published in The Gray Sheet
Executive Summary
AHCPR GUIDELINE ON MANAGEMENT OF CANCER-RELATED PAIN in clinical practice is currently targeted for release this autumn, HHS' Agency for Health Care Policy and Research said. The agency currently has 15 clinical practice guidelines on its schedule for dissemination in 1993 and 1994. Guidelines on the initial evaluation and early treatment of HIV-positive individuals and on the treatment and diagnosis of benign prostatic hyperplasia are anticipated out this summer. Furthest along is a guide on sickle cell disease in newborns and infants, which is scheduled for release April 27. Among the documents to be unveiled in 1993 is a guideline on quality determinants of mammography. Other guides targeted for release some time this year cover the care and evaluation of heart failure; lower back problems (anticipated ready in the late summer/early fall); post-stroke rehabilitation; screening for Alzheimer's and related dementias; and treatment of pressure ulcers in adults. Next year, the HHS agency hopes to have ready clinical practice guidelines on chest pain due to unstable angina; cardiac rehabilitation services; anxiety and panic disorders in primary care; and smoking prevention and cessation. The agency recently released its fifth guideline, which covers depression in the primary care setting.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.